<DOC>
	<DOCNO>NCT02181907</DOCNO>
	<brief_summary>Study investigate bioequivalence UH-AC 62 XX tablet 10 mg ( TF4 ) UH-AC 62 XX capsule 10 mg single administration healthy volunteer .</brief_summary>
	<brief_title>Bioequivalence Study UH-AC 62 XX Tablets Compared With Capsule Formulations Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Age ≥ 20 ≤ 35 year Weight : Body Mass Index ≥ 18.5 &lt; 25 Subjects judge investigator appropriate subject study base result screen test Subjects volunteer participate able fully understand agree study write informed consent History gastrointestinal ulcer surgery gastrointestinal tract ( except appendectomy ) History hypersensitivity UHAC 62 XX ( meloxicam ) salicylate ( aspirin etc . ) Nonsteroidal antiinflammatory drug ( NSAIDs ) History aspirin induce asthma ( bronchial asthma induce NSAIDs ) A tendency bleed History alcohol drug abuse Taking investigational drug within 4 month prior trial Whole blood donation 400 mL within 3 month prior trial Whole blood donation 100 mL within 1 month prior trial Donation constituent blood 400 mL within 1 month prior trial Any medication could influence result trial within 10 day prior trial Excessive physical activity within 7 day prior trial Alcohol drinking within 3 day prior trial History orthostatic hypotension , faint spell blackouts Other , judged investigator inappropriate subject study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>